DocWire News Editors

DocwireNews

Reactions to a diagnosis of autosomal dominant tubule-interstitial kidney disease (ADTKD) due to UMOD and MUC1 mutations in asymptomatic patients are unknown. Researchers in the United States and Czechia developed a cross-sectional survey regarding quality of life and genetic testing for individuals who had undergone genetic testing from families with known ADTKD.Of 622 individuals provided the survey, 286 completed it. Of those, 21% (n=61) were genetically unaffected, 12% (n=3) had stage 1, 2 chronic kidney disease (CKD), 18% (n=51) had stage 3 CKD, 14% (n=41) had stage 4 pre-dialysis CKD, 17% (n=50) were receiving dialysis, and 16% (n=47) were s/p kidney transplantation.Fifty-five respondents thought they had normal kidney function at the time of testing and were found to have ADTKD; 93% of those individuals (n=51) were happy the testing was performed, 5% (n=3) were neutral, and 2% (n=1) was neutral/unhappy. Of the affected individuals, 23% (n=183) said that ADTKD has a &ldquo;substantial effect and I think about it daily.&rdquo; Twenty-six percent (n=47) think about ADTKD weekly, 26% (n=48) think about it monthly, and 26% (n=48) think about it less than monthly,Mean PROMIS&reg; (Patient-Reported Outcomes Measurement Information System) anxiety scores were similar between affected and unaffected individuals and with the general population. Forty-one percent of affected individuals experienced depression compared with 23% of unaffected individuals (P=0.01).&ldquo;Genetic testing of presymptomatic patients for ADTKD is reasonable when requested,&rdquo; the researchers concluded. &ldquo;This study provides reassurance regarding the impact on quality of life of the increased use of genetic testing to diagnosis kidney disease. ADTKD has a significant impact on quality of life, with depression, not anxiety, being more prevalent in affected individuals.&rdquo;<a href="https://www.asn-online.org/education/kidneyweek/2019/program-abstract.aspx?controlId=3231322">Read more here</a>Source: Bleyer A, Kidd KO, Vyletal P, Zivna M, Kmoch S. Quality of life in patients with autosomal dominant tubulointerstitial kidney disease. Abstract of a poster presented at the American Society of Nephrology Kidney Week 2019 (Abstract FR-PO0807), November 8, 2019, Washington, DC.

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Patient Reactions to Genetic Testing for ADTKD

ASN Kidney Week 2019

Reactions to a diagnosis of autosomal dominant tubule-interstitial kidney disease (ADTKD) due to UMOD and MUC1 mutations in asymptomatic patients are unknown. Researchers in ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe